B vitamin polymorphisms and behavior: Evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline

Neuroscience and Biobehavioral Reviews

Volumn 47, Issue , 2014, Pages 307-320

  Mitchell, E Siobhan ^a   Conus, Nelly ^a   Kaput, Jim ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Alzheimer's disease; Autism; Dementia; Folate; Genetics; Geriatric depression; Memory; Mood; Nutrition; Vitamin B12; Vitamin B6; Vitamin B9

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CATECHOL METHYLTRANSFERASE; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; GLUTAMATE CARBOXYPEPTIDASE II; HOMOCYSTEINE; MECOBALAMIN; METHIONINE REDUCTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; OXIDOREDUCTASE; PLACEBO; PYRIDOXINE; TRANSCOBALAMIN II; UNCLASSIFIED DRUG; VITAMIN B GROUP; CELL SURFACE RECEPTOR; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN; TRANSCOBALAMIN RECEPTOR; VITAMIN B COMPLEX;

AUTISM; BEHAVIOR; BIOAVAILABILITY; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DOWN SYNDROME; EPISTASIS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GERIATRIC DISORDER; HUMAN; INTELLIGENCE QUOTIENT; MAJOR DEPRESSION; MILD COGNITIVE IMPAIRMENT; MOOD DISORDER; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PUERPERAL DEPRESSION; REVIEW; SCHIZOPHRENIA; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; GENETICS; GENOTYPE; MENTAL DISEASE; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

CYSTATHIONINE BETA-SYNTHASE; FERREDOXIN-NADP REDUCTASE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MENTAL DISORDERS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; VITAMIN B COMPLEX;

EID: 84922396375     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.08.006     Document Type: Review

References (117)

1. Aisen, P.S., Schneider, L.S., Sano, M., Diaz-Arrastia, R., Van Dyck, C.H., Weiner, M.F., Bottiglieri, T., Jin, S., Stokes, K.T., Thomas, R.G., Thal, L.J., 2008. High-dose B vita-min supplementation and cognitive decline in Alzheimer disease: A randomizedcontrolled trial. JAMA 300, 1774-1783.
2. Aléssio, A.C.M., Höehr, N.F., Siqueira, L.H., Bydlowski, S.P., Annichino-Bizzacchi, J.M., 2007. Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children. Thromb. Res. 119, 571-577.
3. Allen, N.C., Bagade, S., McQueen, M.B., Ioannidis, J.P.A., Kavvoura, F.K., Khoury, M.J., Tanzi, R.E., Bertram, L., 2008. Systematic meta-analyses and field synopsis ofgenetic association studies in schizophrenia: the SzGene database. Nat. Genet. 40, 827-834.
4. Almeida, O.P., Flicker, L., Lautenschlager, N.T., Leedman, P., Vasikaran, S., Van Bock-xmeer, F.M., 2005. Contribution of the MTHFR gene to the causal pathway fordepression, anxiety and cognitive impairment in later life. Neurobiol. Aging 26, 251-257.
5. Almeida, O.P., McCaul, K., Hankey, G.J., Norman, P., Jamrozik, K., Flicker, L., 2008. Homocysteine and depression in later life. Arch. Gen. Psychiatry 65, 1286-1294.
6. Anello, G., Guéant-Rodríguez, R.M., Bosco, P., Guéant, J.L., Romano, A., Namour, B., Spada, R., Caraci, F., Pourié, G., Daval, J.L., Ferri, R., 2004. Homocysteine andmethylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. NeuroReport 15, 859-861.
7. Barbaux, S., Plomin, R., Whitehead, A.S., 2000. Polymorphisms of genes control-ling homocysteine/folate metabolism and cognitive function. NeuroReport 11, 1133-1136.
8. Bathum, L., Von Bornemann Hjelmborg, J., Christiansen, L., McGue, M., Jeune, B., Christensen, K., 2007. Methylenetetrahydrofolate reductase 677C>T andmethionine synthase 2756A>G mutations: no impact on survival, cognitive func-tioning, or cognitive decline in nonagenarians. J. Gerontol. Ser. A: Biol. Sci. Med. Sci. 62, 196-201.
9. Becker, W., Sippl, W., 2011. Activation, regulation, and inhibition of DYRK1A. FEBSJ. 278, 246-256.
10. Beyer, K., Lao, J.I., Latorre, P., Riutort, N., Matute, B., Fernández-Figueras, M.T., Mate, J.L., Ariza, A., 2003. Methionine synthase polymorphism is a risk factor forAlzheimer disease. Neuroreport 14, 1391-1394.
11. Bi, X.-H., Zhao, H.-L., Zhang, Z.-X., Liu, Q., Zhang, J.-W., 2010. Association analysis of CβS 844ins68 and MTHFD1 G1958A polymorphisms with Alzheimer's diseasein Chinese. J. Neural Transm. 117, 499-503.
12. Black, M.M., 2008. Effects of vitamin B12 and folate deficiency on brain developmentin children. Food Nutr. Bull. 29, S126-S131.
13. Bosco, P., Guéant-Rodriguez, R.M., Anello, G., Barone, C., Namour, F., Caraci, F., Romano, A., Romano, C., Guéant, J.L., 2003. Methionine synthase (MTR)2756 (A→G) polymorphism, double heterozygosity methionine synthase 2756AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteine-mia are three risk factors for having a child with down syndrome. Am. J. Med. Genet. 121A, 219-224.
14. Bosco, P., Guéant-Rodríguez, R.M., Anello, G., Romano, A., Namour, B., Spada, R.S., Caraci, F., Tringali, G., Ferri, R., Guéant, J.L., 2004. Association of IL-1 RN*2 alleleand methionine synthase 2756 AA genotype with dementia severity of sporadicAlzheimer's disease. J. Neurol. Neurosurg. Psychiatry 75, 1036-1038.
15. Bonilla, C., Lawlor, D.A., Taylor, A.E., Gunnell, D.J., Ben-Shlomo, Y., Ness, A.R., Timp-son, N.J., St Pourcain, B., Ring, S.M., Emmett, P.M., Smith, A.D., Refsum, H., Pennell, C.E., Brion, M.J., Smith, G.D., Lewis, S.J., 2012. Vitamin B-12 status during preg-nancy and child's IQ at age 8: a Mendelian randomization study in the Avonlongitudinal study of parents and children. PLoS One 7, e51084.
16. Brown, B., Huang, M., Karlamangla, A., Seeman, T., Kado, D., 2011. Do the effectsof APOE-E4 on cognitive function and decline depend upon vitamin status? Macarthur studies of successful aging. J. Nutr. Health Aging 15, 196-201.
17. Brunelli, T., Bagnoli, S., Giusti, B., Nacmias, B., Pepe, G., Sorbi, S., Abbate, R., 2001. TheC677T methylenetetrahydrofolate reductase mutation is not associated withAlzheimer's disease. Neurosci. Lett. 315, 103-105.
18. Burghardt, K.J., Pilsner, J.R., Bly, M.J., Ellingrod, V.L., 2012. DNA methylation inschizophrenia subjects: gender and MTHFR 677C/T genotype differences. Epige-nomics 4, 261-268.
19. Coppen, A., Bolander-Gouaille, C., 2005. Treatment of depression: time to considerfolic acid and vitamin B12. J. Psychopharmacol. (Oxf.) 19, 59-65.
20. de Graaf, A.A., Freidig, A.P., De Roos, B., Jamshidi, N., Heinemann, M., Rullmann, J.A., Hall, K.D., Adiels, M., van Ommen, B., 2009. Nutritional Systems BiologyModeling: From Molecular Mechanisms to Physiology. PLoS Comput. Biol. 5, e1000554, http://dx.doi.org/10.1371/journal.pcbi.1000554.
21. del Río Garcia, C., Torres-Sánchez, L., Chen, J., Schnaas, L., Hernández, C., Osorio, E., Portillo, M.G., López-Carrillo, L., 2009. Maternal MTHFR 677C>T genotype anddietary intake of folate and vitamin B12: their impact on child neurodevelop-ment. Nutr. Neurosci. 12, 13-20.
22. Devlin, A.M., Brain, U., Austin, J., Oberlander, T.F., 2010. Prenatal exposure to mater-nal depressed mood and the MTHFR C677T variant affect SLC6A4 methylationin infants at birth. PLoS ONE 5, e12201.
23. Durga, J., van Boxtel, M.P.J., Schouten, E.G., Bots, M.L., Kok, F.J., Verhoef, P., 2006. Folate and the methylenetetrahydrofolate reductase 677C→T mutation corre-late with cognitive performance. Neurobiol. Aging 27, 334-343.
24. Dutta, S., Shaw, J., Chatterjee, A., Sarkar, K., Usha, R., Chatterjee, A., Sinha, S., Mukhopadhyay, K., 2011. Importance of gene variants and co-factors of folatemetabolic pathway in the etiology of idiopathic intellectual disability. Nutr. Neurosci. 14, 202-209.
25. Elkins, J.S., Johnston, S.C., Ziv, E., Kado, D., Cauley, J.A., Yaffe, K., 2007. Methylene-tetrahydrofolate reductase C677T polymorphism and cognitive function in olderwomen. Am. J. Epidemiol. 166, 672-678.
26. Ellingrod, V.L., Taylor, S.F., Dalack, G., Grove, T.B., Bly, M.J., Brook, R.D., Zöllner, S.K., Pop-Busui, R., 2012. Risk factors associated with metabolic syndrome in bipo-lar and schizophrenia subjects treated with antipsychotics: the role of folatepharmacogenetics. J. Clin. Psychopharmacol. 32, 261-265.
27. Fenech, M., 2010. Folate, DNA damage and the aging brain. Mech. Ageing Dev. 131, 236-241.
28. Feng, L., Li, J., Yap, K.-B., Kua, E.-H., Ng, T.-P., 2009. Vitamin B-12, apolipopro-tein E genotype, and cognitive performance in community-living olderadults: evidence of a gene-micronutrient interaction. Am. J. Clin. Nutr. 89, 1263-1268.
29. Finnell, R.H., Shaw, G.M., Lammer, E.J., Rosenquist, T.H., 2008. Gene-nutrient inter-actions: importance of folk acid and vitamin B12 during early embryogenesis. Food Nutr. Bull. 29, S86-S98.
30. Fintelman-Rodrigues, N., Corrêa, J.C., Santos, J.M., Pimentel, M.M.G., Santos-Rebouças, C.B., 2009. Investigation of CBS, MTR, RFC-1 and TC polymorphismsas maternal risk factors for Down syndrome. Dis. Markers 26, 155-161.
31. Fioravanti, M., Ferrario, E., Massaia, M., Cappa, G., Rivolta, G., Grossi, E., Buckley, A.E., 1997. Low folate levels in the cognitive decline of elderly patients and theefficacy of folate as a treatment for improving memory deficits. Arch. Gerontol. Geriatr. 26, 1-13.
32. Flickera, L., Martins, R.N., Thomas, J., Acres, J., Taddei, K., Norman, P., Jamrozik, K., Almeida, O.P., 2004. Homocysteine, Alzheimer genes and proteins, and measuresof cognition and depression in older men. J. Alzheimer's Dis. 6, 329-336.
33. Ford, A.H., Flicker, L., Alfonso, H., Hankey, G.J., Norman, P.E., Van Bockxmeer, F.M., Almeida, O.P., 2012. Plasma homocysteine and MTHFRC677T polymorphism asrisk factors for incident dementia. J. Neurol. Neurosurg. Psychiatry 83, 70-75.
34. Frankenburg, F.R., 2007. The role of one-carbon metabolism in schizophrenia anddepression. Harv. Rev. Psychiatry 15, 146-160.
35. Frye, R.E., Sequeira, J.M., Quadros, E.V., James, S.J., Rossignol, D.A., 2013. Cerebralfolate receptor autoantibodies in autism spectrum disorder. Mol. Psychiatry 18, 369-381.
36. Garrod, M.G., Allen, L.H., Haan, M.N., Green, R., Miller, J.W., 2010. TranscobalaminC776G genotype modifies the association between vitamin B12 and homocys-teine in older Hispanics. Eur. J. Clin. Nutr. 64, 503-509.
37. Garrod, M.G., Green, R., Allen, L.H., Mungas, D.M., Jagust, W.J., Haan, M.N., Miller, J.W., 2008. Fraction of total plasma vitamin B12 bound to transcobalamin correlateswith cognitive function in elderly latinos with depressive symptoms. Clin. Chem. 54, 1210-1217.
38. Gaysina, D., Cohen, S., Craddock, N., Farmer, A., Hoda, F., Korszun, A., Owen, M.J., Craig, I.W., McGuffin, P., 2008. No association with the 5, 10-methylenetetrahydrofolate reductase gene and major depressive disorder:results of the Depression Case Control (DeCC) study and a meta-analysis. Am. J. Med. Genet. Part B: Neuropsychiat. Genet. 147, 699-706.
39. Goin-Kochel, R.P., Porter, A.E., Peters, S.U., Shinawi, M., Sahoo, T., Beaudet, A.L., 2009. The MTHFR 677C→T polymorphism and behaviors in children with autism:exploratory genotype-phenotype correlations. Autism Res. 2, 98-108.
40. Golimbet, V., Korovaitseva, G., Abramova, L., Kaleda, V., 2009. The 844ins68 polymor-phism of the cystathionine beta-synthase gene is associated with schizophrenia. Psychiatry Res. 170, 168-171.
41. Golimbet, V.E., Lebedeva, I.S., Alfimova, M.V., Barkhatova, A.N., Lezheiko, T.V., Kolesina, N.Y., Borozdina, S.A., Abramova, L.I., 2010. Homocysteine-related genesand attention in patients with schizophrenia and schizoaffective psychosis. Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova 110, 86-89.
42. Gorgone, G., Ursini, F., Altamura, C., Bressi, F., Tombini, M., Curcio, G., Chiovenda, P., Squitti, R., Silvestrini, M., Ientile, R., Pisani, F., Rossini, P.M., Vernieri, F., 2009. Hyperhomocysteinemia, intima-media thickness and C677T MTHFR genepolymorphism: a correlation study in patients with cognitive impairment. Atherosclerosis 206, 309-313.
43. Grapp, M., Just, I.A., Linnankivi, T., Wolf, P., Lücke, T., Häusler, M., Gärtner, J., Steinfeld, R., 2012. Molecular characterization of folate receptor 1 mutations delineatescerebral folate transport deficiency. Brain 135, 2022-2031.
44. Guéant, J.L., Anello, G., Bosco, P., Guéant-Rodríguez, R.M., Romano, A., Barone, C., Gérard, P., Romano, C., 2005. Homocysteine and related genetic poly-morphisms in Down's syndrome IQ. J. Neurol. Neurosurg. Psychiatry 76, 706-709.
45. Guéant, J.L., Guéant-Rodriguez, R.M., Anello, G., Bosco, P., Brunaud, L., Romano, C., Ferri, R., Romano, A., Candito, M., Namour, B., 2003. Genetic determinants offolate and vitamin B12 metabolism: a common pathway in neural tube defectand Down syndrome? Clin. Chem. Lab. Med. 41, 1473-1477.
46. Haggarty, P., 2007. Symposium on 'Genetic polymorphisms and disease risk': B-vitamins, genotype and disease causality. Proc. Nutr. Soc. 66, 539-547.
47. Halsted, C.H., Wong, D.H., Peerson, J.M., Warden, C.H., Refsum, H., Smith, A.D., Nygård, O.K., Ueland, P.M., Vollset, S.E., Tell, G.S., 2007. Relations of glutamatecarboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concen-trations and to scores of cognition, anxiety, and depression in a homogeneousNorwegian population: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 86, 514-521.
48. Hazra, A., Kraft, P., Selhub, J., Giovannucci, E.L., Thomas, G., Hoover, R.N., Chanock, S.J., Hunter, D.J., 2008. Common variants of FUT2 are associated with plasmavitamin B12 levels. Nat. Genet. 40, 1160-1162.
49. Hickie, I., Scott, E., Naismith, S., Ward, P.B., Turner, K., Parker, G., Mitchell, P., Wilhelm, K., 2001. Late-onset depression: genetic, vascular and clinical contributions. Psychol. Med. 31, 1403-1412.
50. Hill, M., Shannahan, K., Jasinski, S., Macklin, E.A., Raeke, L., Roffman, J.L., Goff, D.C., 2011. Folate supplementation in schizophrenia: a possible role for MTHFR geno-type. Schizophr. Res. 127, 41-45.
51. Hong, E.D., Taylor, W.D., McQuoid, D.R., Potter, G.G., Payne, M.E., Ashley-Koch, A., Steffens, D.C., 2009. Influence of the MTHFR C677T polymorphism on magneticresonance imaging hyperintensity volume and cognition in geriatric depression. Am. J. Geriatr. Psychiatry 17, 847-855.
52. Kim, J.M., Stewart, R., Kim, S.W., Yang, S.J., Shin, I.S., Yoon, J.S., 2009. Modification bytwo genes of associations between general somatic health and incident depres-sive syndrome in older people. Psychosom. Med. 71, 286-291.
53. Kim, M.J., Chae, S.S., Koh, Y.H., Lee, S.K., Jo, S.A., 2010. Glutamate carboxypeptidase II:an amyloid peptide-degrading enzyme with physiological function in the brain. FASEB J. 24, 4491-4502.
54. Kruman, I.I., Culmsee, C., Chan, S.L., Kruman, Y., Guo, Z., Penix, L., Mattson, M.P., 2000. Homocysteine elicits a DNA damage response in neurons that promotesapoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20, 6920-6926.
55. Lanctt, K.L., Rapoport, M.J., Chan, F., Rajaram, R.D., Strauss, J., Sicard, T., McCullagh, S., Feinstein, A., Kiss, A., Kennedy, J.L., Bassett, A.S., Herrmann, N., 2010. Geneticpredictors of response to treatment with citalopram in depression secondary totraumatic brain injury. Brain Inj. 24, 959-969.
56. Lewis, S.J., Araya, R., Leary, S., Smith, G.D., Ness, A., 2012. Folic acid supple-mentation during pregnancy may protect against depression 21 months afterpregnancy, an effect modified by MTHFR C677T genotype. Eur. J. Clin. Nutr. 66, 97-103.
57. Lewis, S.J., Lawlor, D.A., Davey Smith, G., Araya, R., Timpson, N., Day, I.N.M., Ebrahim, S., 2006. The thermolabile variant of MTHFR is associated with depression in theBritish Women's Heart and Health Study and a meta-analysis. Mol. Psychiatry 11, 352-360.
58. Li, F., Watkins, D., Rosenblatt, D.S., 2009. Vitamin B12 and birth defects. Mol. Genet. Metab. 98, 166-172.
59. Li, Z.Z., Yu, S.Y., Zhang, C., Yuan, C.M., Hong, W., Wang, Y., Chen, J., Huang, J., Wang, D.X., Fang, Y.R., 2010. Association of MTHFR gene C677T polymorphismsand depression in Han populations. J. Shanghai Jiaotong Univ. (Med. Sci.) 30, 624-627.
60. Lillie, E.O., Patay, B., Diamant, J., Issell, B., Topol, E.J., Schork, N.J., 2011. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Per Med. 8, 161-173.
61. Lizer, M.H., Bogdan, R.L., Kidd, R.S., 2011. Comparison of the frequency of the meth-ylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in depressedversus nondepressed patients. J. Psychiatr. Pract. 17, 404-409.
62. Lok, A., Bockting, C.L.H., Koeter, M.W.J., Snieder, H., Assies, J., Mocking, R.J.T., Vinkers, C.H., Kahn, R.S., Boks, M.P., Schene, A.H., 2013. Interaction between the MTHFRC677T polymorphism and traumatic childhood events predicts depression. Transl. Psychiatry 3, e288.
63. López-León, S., Janssens, A.C.J.W., González-Zuloeta Ladd, A.M., Del-Favero, J., Claes, S.J., Oostra, B.A., Van Duijn, C.M., 2008. Meta-analyses of genetic studies on majordepressive disorder. Mol. Psychiatry 13, 772-785.
64. Lucock, M., Yates, Z., 2006. Synergy between 677 TT MTHFR genotype and relatedfolate SNPs regulates homocysteine level. Nutr. Res. (New York, N.Y.) 26, 180-185.
65. Luder, A., Tanner, S., de la Chapelle, A., Walter, J., 2008. Amnionless (AMN)mutations in Immerlund-Gräsbeck syndrome may be associated with dis-turbed vitamin B(12) transport into the CNS. J. Inherit. Metab. Dis. 097, http://dx.doi.org/10.1007/s10545-007-0760-2.
66. Majumder, D., Mukherjee, A., 2011. A passage through systems biology to systemsmedicine: adoption of middle-out rational approaches towards the understand-ing of therapeutic outcomes in cancer. Analyst 136, 663-678.
67. Malouf, R., Grimley Evans, J., 2008. Folic acid with or without vitamin B12 for theprevention and treatment of healthy elderly and demented people. CochraneDatabase Syst. Rev., CD004514.
68. Malouf, R., Grimley Evans, J., 2008. Folic acid with or without vitamin B12 for theprevention and treatment of healthy elderly and demented people. CochraneDatabase Syst. Rev., CD004514.
69. Martínez-Frías, M.L., 2008. The biochemical structure and function of meth-ylenetetrahydrofolate reductase provide the rationale to interpret theepidemiological results on the risk for infants with Down syndrome. Am. J. Med. Genet. Part A 146A, 1477-1482.
70. McKay, J.A., Groom, A., Potter, C., Coneyworth, L.J., Ford, D., Mathers, J.C., Relton, C.L., 2012. Genetic and non-genetic influences during pregnancy on infant global andsite specific DNA methylation: role for folate gene variants and vitamin B12. PLoSOne 7, e33290.
71. Muntjewerff, J.W., Ophoff, R.A., Buizer-Voskamp, J.E., Strengman, E., den Heijer, M., 2011. Effects of season of birth and a common MTHFR gene variant on the riskof schizophrenia. Eur. Neuropsychopharmacol. 21, 300-305.
72. Naumovski, N., Veysey, M., Ng, X., Boyd, L., Dufficy, L., Blades, B., Travers, C., Lewis, P., Sturm, J., Townley-Jones, M., Yates, Z., Roach, P., Lucock, M., 2010. The folic acidendophenotype and depression in an elderly population. J. Nutr. Health Aging 14, 829-833.
73. Nicodemus, K., Kolachana, B., Vakkalanka, R., Straub, R., Giegling, I., Egan, M., Rujescu, D., Weinberger, D., 2007. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum. Genet. 120, 889-906.
74. Ozbek, Z., Kucukali, C.I., Ozkok, E., Orhan, N., Aydin, M., Kilic, G., Sazci, A., Kara, I., 2008. Effect of the methylenetetrahydrofolate reductase gene polymorphismson homocysteine, folate and vitamin B12 in patients with bipolar disorder andrelatives. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1331-1337.
75. Paşca, S.P., Dronca, E., Kaucsár, T., Crăciun, E.C., Endreffy, E., Ferencz, B.K., Iftene, F., Benga, I., Cornean, R., Banerjee, R., Dronca, M., 2009. One carbon metabolismdisturbances and the C677T MTHFR gene polymorphism in children with autismspectrum disorders. J. Cell. Mol. Med. 13, 4229-4238.
76. Peerbooms, O., Rutten, B.P.F., Collip, D., Lardinois, M., Lataster, T., Thewissen, V., MafiRad, S., Drukker, M., Kenis, G., Van Os, J., Myin-Germeys, I., Van Winkel, R., 2012. Evidence that interactive effects of COMT and MTHFR moderate psychoticresponse to environmental stress. Acta Psychiatr. Scand. 125, 247-256.
77. Peerbooms, O.L.J., van Os, J., Drukker, M., Kenis, G., Hoogveld, L., de Hert, M., Delespaul, P., van Winkel, R., Rutten, B.P.F., 2011. Meta-analysis of MTHFRgene variants in schizophrenia, bipolar disorder and unipolar depressive dis-order: evidence for a common genetic vulnerability? Brain Behav. Immun. 25, 1530-1543.
78. Religa, D., Styczynska, M., Peplonska, B., Gabryelewicz, T., Pfeffer, A., Chodakowska, M., Luczywek, E., Wasiak, B., Stepien, K., Golebiowski, M., Winblad, B., Barcikowska, M., 2003. Homocysteine, apolipoprotein E and methylenetetra-hydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 16, 64-70.
79. Riedel, B.M., Molloy, A.M., Meyer, K., Fredriksen, Å., Ulvik, A., Schneede, J., Nexø, E., Hoff, G., Ueland, P.M., 2011. Transcobalamin polymorphism 67A→G, but Not 776C→G, affects serum holotranscobalamin in a cohort of healthy middle-agedmen and women. J. Nutr. 141, 1784-1790.
80. Roffman, J.L., Brohawn, D.G., Friedman, J.S., Dyckman, K.A., Thakkar, K.N., Agam, Y., Vangel, M.G., Goff, D.C., Manoach, D.S., 2011a. MTHFR 677C
81. Roffman, J.L., Brohawn, D.G., Nitenson, A.Z., Macklin, E.A., Smoller, J.W., Goff, D.C., 2011b. Genetic variation throughout the folate metabolic pathway influencesnegative symptom severity in schizophrenia. Schizophr. Bull. 39, 330-338.
82. Roffman, J.L., Gollub, R.L., Calhoun, V.D., Wassink, T.H., Weiss, A.P., Ho, B.C., White, T., Clark, V.P., Fries, J., Andreasen, N.C., Goff, D.C., Manoach, D.S., 2008a. MTHFR 677C→T genotype disrupts prefrontal function in schizophrenia throughan interaction with COMT 158 Val? Met. Proc. Natl. Acad. Sci. U.S.A. 105, 17573-17578.
83. Roffman, J.L., Lamberti, J.S., Achtyes, E., Macklin, E.A., Galendez, G.C., Raeke, L.H., Silverstein, N.J., Smoller, J.W., Hill, M., Goff, D.C., 2013. Randomized multicenterinvestigation of folate plus vitamin b12 supplementation in schizophrenia. JAMAPsychiatry 70, 481-489.
84. Roffman, J.L., Weiss, A.P., Deckersbach, T., Freudenreich, O., Henderson, D.C., Purcell, S., Wong, D.H., Halsted, C.H., Goff, D.C., 2007. Effects of themethylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on exec-utive function in schizophrenia. Schizophr. Res. 92, 181-188.
85. Roffman, J.L., Weiss, A.P., Deckersbach, T., Freudenreich, O., Henderson, D.C., Wong, D.H., Halsted, C.H., Goff, D.C., 2008b. Interactive effects of COMT Val108/158Metand MTHFR C677T on executive function in schizophrenia. Am. J. Med. Genet. Part B: Neuropsychiatr. Genet. 147, 990-995.
86. Roffman, J.L., Weiss, A.P., Purcell, S., Caffalette, C.A., Freudenreich, O., Henderson, D.C., Bottiglieri, T., Wong, D.H., Halsted, C.H., Goff, D.C., 2008c. Contributionof methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negativesymptoms in schizophrenia. Biol. Psychiatry 63, 42-48.
87. Roth, T.L., Sweatt, J.D., 2011. Annual research review: epigenetic mechanisms andenvironmental shaping of the brain during sensitive periods of development. J. Child Psychol. Psychiatry 52, 398-408.
88. Schaevitz, L.R., Berger-Sweeney, J.E., 2012. Gene-environment interactions and epi-genetic pathways in autism: the importance of one-carbon metabolism. ILAR J. 53, 322-340.
89. Schiepers, O.J.G., van Boxtel, M.P.J., de Groot, R.H.M., Jolles, J., Bekers, O., Kok, F.J., Ver-hoef, P., Durga, J., 2011. Genetic variation in folate metabolism is not associatedwith cognitive functioning or mood in healthy adults. Prog. Neuropsychophar-macol. Biol. Psychiatry 35, 1682-1688.
90. Selhub, J., Morris, M.S., Jacques, P.F., Rosenberg, I.H., 2009. Folate-vitamin B-12 inter-action in relation to cognitive impairment, anemia, and biochemical indicatorsof vitamin B-12 deficiency. Am. J. Clin. Nutr. 89, 702S-706S.
91. Selhub, J., Paul, L., 2011. Folic acid fortification: why not vitamin B12 also? Biofactors 37, 269-271.
92. Semmes, B.J., 2005. Depression: a role for omega-3 fish oils and B vitamins? Evid.-Based Integr. Med. 2, 229-237.
93. Seripa, D., Forno, G.D., Matera, M.G., Gravina, C., Margaglione, M., Palermo, M.T., Wekstein, D.R., Antuono, P., Davis, D.G., Daniele, A., Masullo, C., Bizzarro, A., Gennarelli, M., Fazio, V.M., 2003. Methylenetetrahydrofolate reductase andangiotensin converting enzyme gene polymorphisms in two genetically anddiagnostically distinct cohort of Alzheimer patients. Neurobiol. Aging 24, 933-939.
94. Shaw, G.M., Jelliffe-Pawlowski, L., Nelson, V., Zhu, H., Harris, J.A., Finnell, R.H., 2007. Infant C677T MTHFR polymorphism and severe mental retardation. BirthDefects Res. Part A: Clin. Mol. Teratol. 79, 24-26.
95. Shi, J., Gershon, E.S., Liu, C., 2008. Genetic associations with schizophre-nia: meta-analyses of 12 candidate genes. Schizophr. Res. 104, 96-107.
96. Slopien, R., Jasniewicz, K., Meczekalski, B., Warenik-Szymankiewicz, A., Lianeri, M., Jagodzínski, P.P., 2008. Polymorphic variants of genes encoding MTHFR, MTR, and MTHFD1 and the risk of depression in postmenopausal women in Poland. Maturitas 61, 252-255.
97. Smith, A.D., Smith, S.M., de Jager, C.A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K.M., Jacoby, R., Refsum, H., 2010. Homocysteine-loweringby B vitamins slows the rate of accelerated brain atrophy in mild cognitiveimpairment: a randomized controlled trial. PLoS ONE 5, e12244.
98. Stone, N., Pangilinan, F., Molloy, A.M., Shane, B., Scott, J.M., Ueland, P.M., Mills, J.L., Kirke, P.N., Sethupathy, P., Brody, L.C., 2011. Bioinformatic and genetic associ-ation analysis of microRNA target sites in one-carbon metabolism genes. PLoSONE 6, e21851.
99. Stringer, S., Wray, N.R., Kahn, R.S., Derks, E.M., 2011. Underestimated effect sizes inGWAS: fundamental limitations of single SNP analysis for dichotomous pheno-types. PLoS ONE 6, e27964.
100. Surén, P., Roth, C., Bresnahan, M., Haugen, M., Hornig, M., Hirtz, D., Lie, K.K., Lipkin, W.I., Magnus, P., Reichborn-Kjennerud, T., Schjølberg, S., Davey Smith, G., Øyen, A.S., Susser, E., Stoltenberg, C., 2013. Association between maternal use of folicacid supplements and risk of autism spectrum disorders in children. JAMA 309, 570-577.
101. Sylvia, L.G., Peters, A.T., Deckersbach, T., Nierenberg, A.A., 2013. Nutrient-basedtherapies for bipolar disorder: a systematic review. Psychother. Psychosom. 82, 10-19.
102. Tangney, C.C., Tang, Y., Evans, D.A., Morris, M.C., 2009. Biochemical indicators of vita-min B12 and folate insufficiency and cognitive decline. Neurology 72, 361-367.
103. Taylor, M.J., Carney, S.M., Goodwin, G.M., Geddes, J.R., 2004. Folate for depressivedisorders: systematic review and meta-analysis of randomized controlled trials. J. Psychopharmacol. (Oxf.) 18, 251-256.
104. Tiemeier, H., Ruud van Tuijl, H., Hofman, A., Meijer, J., Kiliaan, A.J., Breteler, M.M.B., 2002. Vitamin B12, folate, and homocysteine in depression: the Rotterdamstudy. Am. J. Psychiatry 159, 2099-2101.
105. Tsai, S.J., Hong, C.J., Yeh, H.L., Liou, Y.J., Yang, A.C., Liu, M.E., Hwang, J.P., 2011. Het-erozygote advantage of the MTHFR C677T polymorphism on specific cognitiveperformance in elderly Chinese males without dementia. Dement. Geriatr. Cogn. Disord. 32, 159-163.
106. Tsutsumi, A., Glatt, S.J., Kanazawa, T., Kawashige, S., Uenishi, H., Hokyo, A., Kaneko, T., Moritani, M., Kikuyama, H., Koh, J., Matsumura, H., Yoneda, H., 2011. The geneticvalidation of heterogeneity in schizophrenia. Behav. Brain Funct., 7.
107. Vares, M., Saetre, P., Deng, H., Cai, G., Liu, X., Hansen, T., Rasmussen, H.B., Werge, T., Melle, I., Djurovic, S., Andreassen, O.A., Agartz, I., Hall, H., Terenius, L., Jönsson, E.G., 2010. Association between methylenetetrahydrofolate reductase (MTHFR)C677T polymorphism and age of onset in schizophrenia. Am. J. Med. Genet. PartB: Neuropsychiatr. Genet. 153, 610-618.
108. Vehof, J., Burger, H., Wilffert, B., Al Hadithy, A., Alizadeh, B.Z., Snieder, H., 2012. Clinical response to antipsychotic drug treatment: association study of poly-morphisms in six candidate genes. Eur. Neuropsychopharmacol. 22, 623-631.
109. Vital Trial Collaborative Group, 2003. Effect of vitamins and aspirin on markers ofplatelet activation oxidative stress and homocysteine in people at high risk ofdementia. J. Intern. Med. 254, 67-75.
110. Vogel, T., Dali-Youcef, N., Kaltenbach, G., Andrès, E., 2009. Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the liter-ature. Int. J. Clin. Pract. 63, 1061-1067.
111. Wilson, C.P., McNulty, H., Scott, J.M., Strain, J.J., Ward, M., 2010. Postgraduate sym-posium The MTHFR C677T polymorphism, B-vitamins and blood pressure. Proc. Nutr. Soc. 69, 156-165.
112. Witte, A.V., Flöel, A., 2012. Effects of COMT polymorphisms on brain function andbehavior in health and disease. Brain Res. Bull.
113. Wu, Y.-L., Ding, X.-X., Sun, Y.-H., Yang, H.-Y., Chen, J., Zhao, X., Jiang, Y.-H., Lv, X.-L., Wu, Z.-Q., 2013. Association between MTHFR C677T polymorphism and depres-sion: an updated meta-analysis of 26 studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 46, 78-85.
114. Ye, X., Lai, C.Q., Crott, J.W., Troen, A.M., Ordovas, J.M., Tucker, K.L., 2011. The folatehydrolase 1561c>t polymorphism is associated with depressive symptoms inPuerto Rican adults. Psychosom. Med. 73, 385-392.
115. Yoshimi, A., Aleksic, B., Kawamura, Y., Takahashi, N., Yamada, S., Usui, H., Saito, S., Ito, Y., Iwata, N., Inada, T., Noda, Y., Yamada, K., Ozaki, N., 2010. Gene-wide asso-ciation study between the methylenetetrahydrofolate reductase gene (MTHFR)and schizophrenia in the Japanese population, with an updated meta-analysison currently available data. Schizophr. Res. 124, 216-222.
116. Yuan, Y.G., Zhang, Z.J., Li, J.J., 2008. Plasma homocysteine but not MTHFR gene poly-morphism is associated with geriatric depression in the Chinese population. Acta Neuropsychiatr. 20, 251-255.
117. Zetterberg, H., Nexö, E., Regland, B., Minthon, L., Boson, R., Palmér, M., Rymo, L., Blennow, K., 2003. The transcobalamin (TC) codon 259 genetic polymorphisminfluences holo-TC concentration in cerebrospinal fluid from patients withAlzheimer disease. Clin. Chem. 49, 1195-1198.
118. Zintzaras, E., 2006. C677T and A1298C methylenetetrahydrofolate reductase genepolymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr. Genet. 16, 105-115.